NDANASALSPRAY, METEREDPriority Review
Approved
Nov 2015
Lifecycle
Peak
Competitive Pressure
30/100
Clinical Trials
1
Data completeness
2/8 — Basic
Priority Review
Drug data last refreshed 3h ago · AI intelligence enriched 1w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
NARCAN is a metered nasal spray formulation of naloxone hydrochloride, an opioid antagonist approved in 2015 for rapid reversal of opioid overdose. It works by competitively binding to opioid receptors, displacing opioids and rapidly restoring normal respiration. The nasal route enables non-medical personnel to administer the drug without injection training.
Peak
Peak lifecycle position with moderate competitive pressure (30%) indicates sustained revenue but increased defensive commercial activity.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Clinical Trials (1)
Pharmacodynamic Evaluation of Intramuscular Nalmefene Autoinjector 1.5 mg Compared to Intranasal Narcan 4 mg
Started Oct 2022
24 enrolled
Opioid Overdose
Career Relevance
Working on NARCAN offers unique exposure to public health policy, government relations, and non-traditional commercial channels given the drug's role in the opioid crisis response. Positions tend to emphasize stakeholder engagement, reimbursement strategy, and access initiatives rather than traditional pharmaceutical promotion.
Brand Manager
Worked on NARCAN at Emergent BioSolutions? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.